Orexo Future Growth
Future criteria checks 4/6
Orexo is forecast to grow earnings and revenue by 74.3% and 13.2% per annum respectively. EPS is expected to grow by 74.3% per annum. Return on equity is forecast to be 8.8% in 3 years.
Key information
74.3%
Earnings growth rate
74.3%
EPS growth rate
Pharmaceuticals earnings growth | 66.8% |
Revenue growth rate | 13.2% |
Future return on equity | 8.8% |
Analyst coverage | Low |
Last updated | 18 Jul 2024 |
Recent future growth updates
Recent updates
Orexo AB (publ) (STO:ORX) Might Not Be As Mispriced As It Looks After Plunging 28%
Aug 02Orexo AB (publ) (STO:ORX) Just Reported Earnings, And Analysts Cut Their Target Price
Jul 20Orexo AB (publ) (STO:ORX) Soars 28% But It's A Story Of Risk Vs Reward
May 29Orexo AB (publ)'s (STO:ORX) Business And Shares Still Trailing The Industry
Apr 03We Think Orexo (STO:ORX) Has A Fair Chunk Of Debt
Dec 09Orexo AB (publ)'s (STO:ORX) Intrinsic Value Is Potentially 24% Below Its Share Price
Jun 14Is Orexo (STO:ORX) A Risky Investment?
Apr 27Orexo AB (publ)'s (STO:ORX) Intrinsic Value Is Potentially 92% Above Its Share Price
Oct 19Would Orexo (STO:ORX) Be Better Off With Less Debt?
Sep 09Are Investors Undervaluing Orexo AB (publ) (STO:ORX) By 47%?
May 26Is Orexo (STO:ORX) Using Too Much Debt?
Apr 16Orexo (STO:ORX) Has Debt But No Earnings; Should You Worry?
May 04Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 790 | 15 | 79 | 84 | 1 |
12/31/2025 | 627 | -77 | -10 | -5 | 1 |
12/31/2024 | 595 | -97 | -24 | -17 | 1 |
6/30/2024 | 615 | -97 | -61 | -50 | N/A |
3/31/2024 | 619 | -73 | -72 | -52 | N/A |
12/31/2023 | 639 | -128 | -114 | -95 | N/A |
9/30/2023 | 629 | -201 | -172 | -141 | N/A |
6/30/2023 | 634 | -195 | -205 | -180 | N/A |
3/31/2023 | 624 | -218 | -176 | -157 | N/A |
12/31/2022 | 624 | -178 | -180 | -157 | N/A |
9/30/2022 | 612 | -152 | -203 | -188 | N/A |
6/30/2022 | 597 | -177 | -241 | -207 | N/A |
3/31/2022 | 592 | -216 | -285 | -243 | N/A |
12/31/2021 | 565 | -223 | -282 | -229 | N/A |
9/30/2021 | 580 | -207 | -239 | -160 | N/A |
6/30/2021 | 585 | -240 | -201 | -93 | N/A |
3/31/2021 | 621 | -198 | -281 | -79 | N/A |
12/31/2020 | 664 | -84 | -173 | 17 | N/A |
9/30/2020 | 743 | 4 | -94 | 84 | N/A |
6/30/2020 | 824 | 201 | 89 | 231 | N/A |
3/31/2020 | 846 | 288 | 248 | 284 | N/A |
12/31/2019 | 845 | 219 | 255 | 287 | N/A |
9/30/2019 | 834 | 232 | 286 | 302 | N/A |
6/30/2019 | 819 | 182 | 192 | 194 | N/A |
3/31/2019 | 818 | 178 | 183 | 187 | N/A |
12/31/2018 | 783 | 138 | 238 | 242 | N/A |
9/30/2018 | 747 | 113 | 144 | 147 | N/A |
6/30/2018 | 697 | 79 | 212 | 215 | N/A |
3/31/2018 | 656 | 32 | N/A | 225 | N/A |
12/31/2017 | 644 | 23 | N/A | 147 | N/A |
9/30/2017 | 637 | 19 | N/A | 241 | N/A |
6/30/2017 | 653 | 27 | N/A | 191 | N/A |
3/31/2017 | 682 | 29 | N/A | 151 | N/A |
12/31/2016 | 706 | 29 | N/A | 156 | N/A |
9/30/2016 | 752 | -57 | N/A | 84 | N/A |
6/30/2016 | 710 | -139 | N/A | -38 | N/A |
3/31/2016 | 648 | -229 | N/A | -82 | N/A |
12/31/2015 | 646 | -210 | N/A | -109 | N/A |
9/30/2015 | 636 | -95 | N/A | -116 | N/A |
6/30/2015 | 627 | -85 | N/A | -188 | N/A |
3/31/2015 | 617 | -51 | N/A | -381 | N/A |
12/31/2014 | 570 | -57 | N/A | -487 | N/A |
9/30/2014 | 449 | -146 | N/A | -593 | N/A |
6/30/2014 | 440 | -138 | N/A | -671 | N/A |
3/31/2014 | 391 | -204 | N/A | -358 | N/A |
12/31/2013 | 429 | -155 | N/A | -263 | N/A |
9/30/2013 | 413 | -139 | N/A | -227 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ORX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.1%).
Earnings vs Market: ORX is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ORX is expected to become profitable in the next 3 years.
Revenue vs Market: ORX's revenue (13.2% per year) is forecast to grow faster than the Swedish market (1.1% per year).
High Growth Revenue: ORX's revenue (13.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ORX's Return on Equity is forecast to be low in 3 years time (8.8%).